review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1037127203 |
P356 | DOI | 10.2165/00003495-198122040-00001 |
P698 | PubMed publication ID | 7030707 |
P2093 | author name string | V M Campese | |
P2860 | cites work | Need for beta-blockade in hypertension reduced with long-term minoxidil | Q28317132 |
Acute cardiomyopathy induced by the vasodilating antihypertensive agent minoxidil | Q28326717 | ||
Hypertrichosis due to minoxidil | Q28328717 | ||
Clinical and haemodynamic effects of minoxidil in refractory hypertension | Q28328983 | ||
Metabolism of minoxidil, a new hypotensive agent II: biotransformation following oral administration to rats, dogs, and monkeys | Q28329655 | ||
Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide | Q28339392 | ||
Minoxidil in severe hypertension: value when conventional drugs have failed | Q28339588 | ||
Minoxidil-induced hypertrichosis: treatment with calcium thioglycolate depilatory | Q34366321 | ||
Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity | Q34473162 | ||
Hypertrichosis lanuginosa associated with diazoxide therapy in prepubertal children: a clinicopathologic study | Q34702102 | ||
Long-term treatment of severe hypertension with minoxidil | Q35817735 | ||
Treatment of severe hypertension with minoxidil | Q39064011 | ||
Clonidine and the vasodilating beta blocker antihypertensive drug interaction | Q39154966 | ||
Minoxidil in Severe Hypertension | Q39183865 | ||
Minoxidil in refractory hypertension. Effects on blood pressure, plasma volume and muscle blood flow | Q39241599 | ||
Double-Blind Comparison of Minoxidil and Hydrallazine in Severe Hypertension | Q39811101 | ||
The pharmacologic basis of antihypertensive therapy: The role of vasodilator drugs | Q39874716 | ||
Pharmacology and Pharmacokinetics of Minoxidil | Q40098145 | ||
[Clinical experiences with minoxidil, a new antihypertensive agent] | Q68884775 | ||
Pharmacologic properties of minoxidil: a new hypotensive agent | Q69381505 | ||
Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs | Q69481858 | ||
Bilateral nephrectomy for control of hypertension in uremia | Q69863610 | ||
Hirsutism | Q69878772 | ||
Mechanisms of autonomic nervous system dysfunction in uremia | Q70183489 | ||
Pharmacokinetic studies of minoxidil | Q70374165 | ||
Myocardial papillary muscle necrosis induced by hypotensive agents in dogs | Q70635125 | ||
Renal function during long-term treatment of hypertension with minoxidil: comparison of benign and malignant hypertension | Q70716937 | ||
Minoxidil: right atrial cardiac pathology in animals and in man | Q71263093 | ||
Plasma Renin Activity and Blood Pressure in Terminal Renal Failure | Q71815735 | ||
Uremic pericarditis. Clinical features and management | Q72096635 | ||
Treatment of Refractory Hypertension with Minoxidil | Q72612354 | ||
Minoxidil in the treatment of refractory hypertension due to a spectrum of causes | Q72612362 | ||
Efficacy of minoxidil in the treatment of severe hypertension in systemic disorders | Q72612365 | ||
Long-Term Treatment With Minoxidil in Patients With Severe Renal Failure | Q72612367 | ||
Clinical Response of Hypertensive Children to Long-Term Minoxidil Therapy | Q72612369 | ||
Rapid reduction of severe hypertension with minoxidil | Q72612371 | ||
Serial Electrocardiographic Changes During Long-Term Treatment of Server Hypertension with Minoxidil | Q72612374 | ||
Pericardial Disorders Occurring During Open-Label Study of 1,869 Severely Hypertensive Patients Treated with Minoxidil | Q72612378 | ||
Minoxidil in the Management of Moderate Hypertension | Q72612384 | ||
Circulatory studies in hypertensive patients at rest and during exercise, with a note on the Starling relationship in the left ventricle in essential hypertension | Q74489542 | ||
Bilateral nephrectomy for malignant hypertension | Q93721209 | ||
Minoxidil and the treatment of severe hypertension | Q40290314 | ||
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy | Q40300185 | ||
Altered renin release and propranolol potentiation of vasodilatory drug hypotension | Q40317304 | ||
Minoxidil--haemodynamic and clinical experiences with a new peripheral vasodilator | Q40329388 | ||
The physiological basis of thirst | Q40564696 | ||
Long-term experiences with minoxidil in combination treatment of severe arterial hypertension | Q40665598 | ||
Minoxidil therapy in children with severe hypertension | Q40766284 | ||
Effect of minoxidil on blood pressure and hemodynamics in severe hypertension | Q40770064 | ||
Long-Term Clinical Effects, Bioavailability, and Kinetics of Minoxidil in Relation to Renal Function | Q40956673 | ||
Minoxidil in severe hypertension | Q40977516 | ||
Treatment of Severe Hypertension with Minoxidil: Advantages and Limitations | Q41035180 | ||
Vasodilating antihypertensive drug-induced aldosterone release--a study of endogenous angiotensin-mediated aldosterone release in the rat | Q41071181 | ||
Toxicologic studies with the hypotensive agent minoxidil | Q41232877 | ||
Rapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone system | Q41603963 | ||
Renal Function and Vascular Resistance During Long-Term Minoxidil Treatment of Severe Hypertension | Q42242755 | ||
Long-term effects of minoxidil therapy on renal function of patients with refractory hypertension: the significance of albuminuria | Q42242759 | ||
Renal Function in Long-Term Minoxidil-Treated Patients | Q42242761 | ||
Rebound hypertension following minoxidil withdrawal | Q42271636 | ||
Hazards in treatment of systolic hypertension | Q43630522 | ||
Comparative splanchnic blood flow effects of various vasodilator compounds | Q43945925 | ||
Minoxidil Increases Aldosterone Metabolic Clearance in Hypertensive Patients* | Q43995962 | ||
Use of Minoxidil in the Azotemic Patient | Q44267151 | ||
Treatment of severe and moderate hypertension with minoxidil: experience in twenty-eight patients | Q44952074 | ||
Renal failure, uncontrollable thirst, and hyperreninemia. Cessation of thirst with bilateral nephrectomy | Q48632122 | ||
Urgent bilateral nephrectomy for severe hypertension | Q48766574 | ||
Drinking induced by injection of angiotensin into the rain of the rat. | Q48900874 | ||
A central effect of angiotensin: release of pituitary pressor material | Q48910238 | ||
Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. | Q53829232 | ||
Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil. | Q54175978 | ||
Unusual Cases of Resistance to Minoxidil Therapy | Q54563726 | ||
Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses. | Q54563730 | ||
Minoxidil for severe hypertension after failure of other hypotensive drugs. | Q54594123 | ||
The effects of minoxidil on pulmonary and systemic hemodynamics in hypertensive man. | Q54600664 | ||
Minoxidil reduces pulmonary vascular resistance in dogs and cattle. | Q54605370 | ||
Severe hypertension. Treatment with minoxidil. | Q54624274 | ||
Tissue distribution and hypotensive effects of minoxidil in normotensive rats. | Q54659828 | ||
Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine. | Q55061463 | ||
The control of hypertension in patients undergoing regular maintenance hemodialysis | Q66844963 | ||
Vasodilating drugs: contrasting haemodynamic effects | Q66864186 | ||
The use of minoxidil in the treatment of severe essential hypertension: a report on 100 patients | Q66864188 | ||
Treatment of severe hypertension with minoxidil and its effects on systemic and pulmonary haemodynamics | Q66864190 | ||
Minoxidil Therapy in Refractory Hypertension Analysis of 155 Patients | Q66888516 | ||
Pulmonary hemodynamics in systemic hypertension. Long-term effect of minoxidil | Q66923022 | ||
A method for achieving blood pressure control expeditiously with oral minoxidil | Q66956028 | ||
Minoxidil therapy for refractory hypertension and chronic renal failure | Q66968374 | ||
Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension | Q67269234 | ||
Long-Term Treatment of Refractory Hypertensive Patients With Minoxidil | Q67319333 | ||
Effects of minoxidil on coronary collateral flow and acute myocardial injury following experimental coronary artery occlusion | Q67325594 | ||
The dominance of adrenergic mechanisms in mediating hypotensive drug-induced renin release in the conscious rat | Q67469804 | ||
Long-term effects of minoxidil in the treatment of malignant hypertension in chronic renal failure | Q67493931 | ||
Minoxidil treatment of severe hypertension | Q67509692 | ||
Increased pulmonary vascular resistance with systemic hypertension. Effect of minoxidil and other antihypertensive agents | Q67584182 | ||
Management of severe childhood hypertension with minoxidil: a controlled clinical study | Q67587323 | ||
Minoxidil--an alternative to nephrectomy for refractory hypertension | Q68510756 | ||
P433 | issue | 4 | |
P304 | page(s) | 257-278 | |
P577 | publication date | 1981-10-01 | |
P1433 | published in | Drugs | Q3040094 |
P1476 | title | Minoxidil: a review of its pharmacological properties and therapeutic use. | |
P478 | volume | 22 |
Q38031524 | Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney |
Q33160283 | Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management |
Q47913024 | Clinical pharmacokinetics of vasodilators. Part I. |
Q34742268 | Clinical pharmacology of antihypertensive drugs |
Q70562523 | Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension |
Q41600656 | Current clinical pathophysiologic considerations in essential hypertension |
Q52560083 | Diagnosis and management of resistant hypertension: state of the art. |
Q38512174 | Direct Vasodilators and Sympatholytic Agents |
Q57023536 | Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases |
Q34708717 | Drug Prescribing in Renal Failure: Dosing Guidelines for Adults |
Q34407512 | Effect of topically applied minoxidil on the survival of rat dorsal skin flap |
Q39548978 | Guide to drug dosage in renal failure |
Q35738465 | Hypertension and the vascular patient |
Q39166266 | Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension |
Q36138286 | Influence of antihypertensive therapy on renal function |
Q69643748 | Minoxidil analysis in human plasma using high-performance liquid chromatography with electrochemical detection. Application to pharmacokinetic studies |
Q68879454 | Minoxidil and captopril in severe hypertension |
Q93184657 | Minoxidil and its use in hair disorders: a review |
Q39720651 | Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis |
Q35046070 | Minoxidil opens mitochondrial K(ATP) channels and confers cardioprotection |
Q72753418 | Minoxidil sulphation in human liver and platelets. A study of interindividual variability |
Q84091149 | Minoxidil therapy in children and young adult patients with renal disease and refractory hypertension: value when multidrug regimens have failed to achieve blood pressure control |
Q87855187 | Stability of an extemporaneously compounded minoxidil oral suspension |
Q41307636 | The pharmacokinetics of 2.5- to 10-mg oral doses of minoxidil in healthy volunteers |
Q37598885 | Therapeutic applications of drugs acting on peripheral dopamine receptors |
Q58282548 | Three Methods for the Quantitative Determination of Minoxidil |
Q49382561 | Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial. |
Q39764424 | Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica |
Q35023961 | Treatment of hypertension from volume to vasoconstriction: The ACE up your sleeve |
Search more.